Navigation Links
Thomson Reuters White Paper Explores the Role of Biomarkers in Clinical Trials and Drug Development
Date:1/12/2009

PHILADELPHIA and LONDON, Jan. 12 /PRNewswire-FirstCall/ -- Thomson Reuters today announced that it has published a new white paper on the topic of biomarkers drawing on expert insight from academics and key players in the pharmaceuticals industry. Called "Biomarkers: An Indispensable Addition to the Drug Development Toolkit," it explores the role of biomarkers as evaluative tools in addressing some of the challenges seen in clinical research and their potential to improve decision making, accelerate drug development and reduce development costs.

Used as a way to measure normal biological processes in the body, pathological processes, or the response of the body to a therapeutic intervention, Biomarkers have become an essential part of clinical development because they potentially offer a faster route to market versus the conventional drug development approach, where success rates have steadily declined in recent years. Attrition rates for drugs in discovery and development are currently very high with less than 10% of tested products entering phase I trials. With increasing costs involved in the drug development process, and growing concern that fewer drugs are making it through to the marketplace each year, the pharmaceutical industry is embracing biomarkers as a way of predicting a drug candidate's performance early and with a greater degree of certainty.

"The FDA, as well as academic and research organizations, have recognized Biomarkers as having great potential to speed the development and approval of medical products," said Wendy Hamilton, vice president of product strategy and marketing, Scientific business of Thomson Reuters. "Because biomarkers can predict drug efficacy and safety more quickly than conventional clinical endpoints, they hold the potential to substantially accelerate product development, and because they help to identify earlier those drug candidates that are likely to fail, they reduce drug develo
'/>"/>

SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Lupus is a Significant Cost to Employers, According to Thomson Reuters Study
2. Clinical Xpert Navigator From Thomson Reuters Is Named Best Mobile Data System in the KLAS Awards - for Seventh Consecutive Year
3. BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy
4. Companies Pay a High Price for Employees With Crohns Disease and Ulcerative Colitis, According to Study From Thomson Reuters
5. Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters
6. Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders
7. Thomson Reuters Survey Finds Cancer Patients Forgoing Treatment Because of Cost
8. The Scientific Business of Thomson Reuters Predicts Nobel Laureates
9. Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters
10. The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008
11. Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SMITHFIELD, R.I., Dec. 1 /PRNewswire/ ...bad assumptions are hazardous and can result in in...ent regulation, a handful of persistent bad assump...tiveness of occupational Hearing Conservation Pro...free, white paper from Howard Leight, " Bad Ass...
(Date:12/1/2009)..., ,, NEW YORK, Dec. 1 Ovi...er in the development and delivery of customizable...scientific and academic markets, will be showcasin...r first-to-market cross-platform search solution, ..., based on the American Psychological Association,...
(Date:12/1/2009)...TON, Dec. 1 The followi...ational Development: ,, Chairman Kerry, Ranking... I am honored to be nominated by President Obama t...cy for International Development, and I appreciate...ecretary of State Clinton has expressed the convic...
(Date:12/1/2009)...tient Safety Authority Encourages Older Persons an...ew Consumer Tips Based Upon Authority Data ,,...- Ninety percent of all vaccine preventable deaths...in nursing homes, according to highlighted studies...09 December Patient Safety Advisory . ,, Accor...
(Date:12/1/2009)...vember 2009. Performing surgical operations witho...s become a reality. This is demonstrated by the re...rifice Transluminal Endoscopy Surgery), an innovat...using the body,s natural orifices. The results are...shorter hospital stay and faster recovery. Current...
Breaking Medicine News(10 mins):Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3
...lms Help Increase Public Understanding of a,21st C...ging of the,population, experts warn that Alzheime...-century, creating massive and unsustainable burde...com/cgi-bin/prnh/20080312/DC16505-a ), (Photo: ...
... Cardiac Science,Corporation (Nasdaq: CSCX ), a ...itation, rehabilitation, and informatics products,...ngton Biotechnology and Biomedical,Association (WB... and chief financial officer, will review the Comp...
...by new cases among gay, bisexual men, CDC reports ...- For the seventh year in a row, rates of syphilis...iven largely by cases among gay and bisexual men, ...fectious stages of the disease -- increased by 12 ...
... is a nuclear protein well known for its crucial r...rentiation and activation of T cells, making it a ... revealed a darker side: it is an essential contri...ls break away from the original tumor and spread t...
...rchers have developed a new, lean mouse with chara...on to manipulate a specific protein in humans coul...ers associated with excess weight, such as diabete...n animal used in research for studying diabetes an...
...op to convene at Northwestern Memorial June,19-21,...bout their healthcare experiences in America and c...ation, medical error, or expected outcomes gone,wr... United States. Even when the outcomes are not cat...
Other Medicine News:Health News:New Tools Boost Alzheimer's Awareness 2Health News:New Tools Boost Alzheimer's Awareness 3Health News:Cardiac Science to Present at the Seventh Annual Invest Northwest Conference 2Health News:U.S. Syphilis Rate Grows for 7th Year in Row 2Health News:U.S. Syphilis Rate Grows for 7th Year in Row 3Health News:A protein that triggers aggressive breast cancer 2Health News:A protein that triggers aggressive breast cancer 3Health News:A protein that triggers aggressive breast cancer 4Health News:A protein that triggers aggressive breast cancer 5Health News:Protein deficiency leads to faster fat burning in mice, study shows 2Health News:Protein deficiency leads to faster fat burning in mice, study shows 3Health News:Northwestern Memorial Hospital, CAPS, and p4ps Host Consumer Forum to Advance Partnerships to Improve Healthcare Patient Safety 2Health News:Northwestern Memorial Hospital, CAPS, and p4ps Host Consumer Forum to Advance Partnerships to Improve Healthcare Patient Safety 3Health News:Northwestern Memorial Hospital, CAPS, and p4ps Host Consumer Forum to Advance Partnerships to Improve Healthcare Patient Safety 4
(Date:12/1/2009)... , MORRISVILLE, N.C., Dec. 1 ...the investigation of devices for minimally-invasiv...the initiation of a feasibility clinical trial des...bined surgical and catheter procedure, the converg...roxysmal atrial fibrillation (AF). This prospecti...
(Date:12/1/2009)... , PISCATAWAY, N.J., Dec. 1 ...ens.com/hearing) a leading global manufacturer of ...rtnership with Quota International,s Sound Beginni...h September 2010. ,, As part of the renewed par...ide vouchers for 100 free hearing instruments to b...
(Date:12/1/2009)... , SAN DIEGO, Dec. 1 ...today announced that a new, recently completed pre... comparable toxicity of ANX-514 and Taxotere®...X,s partner for ANX-514 in South Korea, independen... "Our independent confirmation of the bioequivalen...
Breaking Medicine Technology:nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Surviving mass extinction by leading a double life 9262 1Surviving mass extinction by leading a double life 9262 2 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 1 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 2 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 3 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 4Nominate the Parentgivers of the Year 51654 1Nominate the Parentgivers of the Year 51654 2
...harmaceuticals Inc. announced today that data on C...im) will be presented at the 50th Annual Meeting o...cember 6-9, 2008 in San Francisco, California. , ... and hematology research centers will present data...orting important findings in leukemia-related diso...
...rporation,(Nasdaq: THOR ), a world leader in dev... to save, support and restore failing hearts, said...ta from its HeartMate II Destination,Therapy (DT) ...he device,achieved statistically superior outcomes...ted with the company,s HeartMate XVE. The DT study...
Other Medicine Technology:Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 2Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 3Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 4Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 5Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 6Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 2Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 3Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 4
Carbon fiber locking handle (with cautery)
Carbon fiber ratchet handle (on and off ratchet with cautery)
Uninsulated stainless steel locking handle
Micro Scissors, dual-incision
Medicine Products: